Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Isabelle Mahé, Céline Chapelle, Philippe Girard, Marc Carrier, Luis Jara Palomares, Charles Marc Samama, Hélène Helfer, Grigoris Gerotziafas, Silvy Laporte, Éric Vicaut, Patrick Mismetti, Isabelle Mahé, Silvy Laporte, Didier Mayeur, Giancarlo Agnelli, Cecilia Becattini, Manuel Monréal, Juan José LÓPEZ-NÚÑEZ, Peter Verhamme, Adam Torbicki, Sebastian Szmit, Marc Righini, Alexander T. Cohen, Anthony Maraveyas, Menno Huisman, Frederikus A. Klok, Kostas N. Syrigos, Aristotelis Bamias, Cihan AY, Marc Carrier, Grégoire Le Gal, Éric Vicaut (2025). Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial. , DOI: https://doi.org/10.1016/s2352-3026(25)00291-1.
